{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:52:11Z","timestamp":1792839131425,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18CDA34110131"],"award-info":[{"award-number":["18CDA34110131"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"AGAUR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SGR"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1053\/j.ajkd.2020.03.016","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T18:04:25Z","timestamp":1593626665000},"page":"710-719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Clinical Application of Kidney Biomarkers in Cirrhosis"],"prefix":"10.1053","volume":"76","author":[{"given":"Andrew S.","family":"Allegretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Sol\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gin\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1053\/j.ajkd.2020.03.016_bib1","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gines","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1053\/j.ajkd.2020.03.016_bib2","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/03007995.2017.1331211","article-title":"The burden of hepatorenal syndrome among commercially insured and Medicare patients in the United States","volume":"33","author":"Rice","year":"2017","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.016_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.016_bib4","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/ndt\/gfm744","article-title":"A\u00a0multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients","volume":"23","author":"Bagshaw","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2020.03.016_bib5","doi-asserted-by":"crossref","first-page":"108139","DOI":"10.1155\/2015\/108139","article-title":"Prognosis of acute kidney injury and hepatorenal syndrome in patients with cirrhosis: a prospective cohort study","volume":"2015","author":"Allegretti","year":"2015","journal-title":"Int J Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2215\/CJN.03610417","article-title":"Prognosis of patients with cirrhosis and AKI who initiate RRT","volume":"13","author":"Allegretti","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.016_bib7","doi-asserted-by":"crossref","first-page":"496.e494","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis","volume":"140","author":"Martin-Llahi","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1053\/j.ajkd.2020.03.016_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1665-2681(19)30870-1","article-title":"Akin criteria as a predictor of mortality in cirrhotic patients after spontaneous bacterial peritonitis","volume":"13","author":"de Araujo","year":"2014","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.016_bib9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association of AKI with mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2011-301255","article-title":"Acute kidney injury in decompensated cirrhosis","volume":"62","author":"Tsien","year":"2013","journal-title":"Gut"},{"issue":"3","key":"10.1053\/j.ajkd.2020.03.016_bib11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A\u00a0modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis","volume":"59","author":"Fagundes","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1053\/j.ajkd.2020.03.016_bib12","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1097\/CCM.0000000000001102","article-title":"Persistent acute kidney injury","volume":"43","author":"Kellum","year":"2015","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.016_bib13","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gines","year":"1993","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1053\/j.ajkd.2020.03.016_bib15","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.016_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.016_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archinte.1994.00420020117013","article-title":"Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis","volume":"154","author":"Caregaro","year":"1994","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1053\/j.ajkd.2020.03.016_bib18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/lt.22128","article-title":"Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score","volume":"16","author":"Francoz","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1053\/j.ajkd.2020.03.016_bib19","first-page":"CD005162","article-title":"Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome","volume":"6","author":"Allegretti","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.ajkd.2020.03.016_bib20","first-page":"CD011532","article-title":"Terlipressin versus other vasoactive drugs for hepatorenal syndrome","volume":"9","author":"Israelsen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.016_bib21","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2215\/CJN.12451018","article-title":"Hepatorenal syndrome","volume":"14","author":"Francoz","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2020.03.016_bib22","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1007\/s10620-016-4316-x","article-title":"Siglec-7 as a novel biomarker to predict mortality in decompensated cirrhosis and acute kidney injury","volume":"61","author":"Allegretti","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.016_bib23","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.30230","article-title":"Serum angiopoietin-2 predicts mortality and kidney outcomes in decompensated cirrhosis","volume":"69","author":"Allegretti","year":"2019","journal-title":"Hepatology"},{"issue":"7","key":"10.1053\/j.ajkd.2020.03.016_bib24","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/liv.14037","article-title":"Characterization of inflammatory response in hepatorenal syndrome: relationship with kidney outcome and survival","volume":"39","author":"Sole","year":"2018","journal-title":"Liver Int"},{"key":"10.1053\/j.ajkd.2020.03.016_bib25","doi-asserted-by":"crossref","first-page":"32341","DOI":"10.1038\/srep32341","article-title":"Characterization of inflammatory response in acute-on-chronic liver failure and relationship with prognosis","volume":"6","author":"Sole","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1053\/j.ajkd.2020.03.016_bib27","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.016_bib28","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A\u00a0model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"issue":"6","key":"10.1053\/j.ajkd.2020.03.016_bib29","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.016_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1523-1755.2003_t01-1-00784.x","article-title":"Pathophysiology of pre-renal azotemia","volume":"53","author":"Blantz","year":"1998","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2010111124","article-title":"Imperfect gold standards for kidney injury biomarker evaluation","volume":"23","author":"Waikar","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.016_bib32","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1053\/j.ajkd.2010.05.011","article-title":"Defining acute kidney injury in database studies: the effects of varying the baseline kidney function assessment period and considering CKD status","volume":"56","author":"Lafrance","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.016_bib33","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2215\/CJN.10821011","article-title":"Estimating baseline kidney function in hospitalized patients with impaired kidney function","volume":"7","author":"Siew","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2020.03.016_bib34","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1681\/ASN.2008070669","article-title":"Creatinine kinetics and the definition of acute kidney injury","volume":"20","author":"Waikar","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2020.03.016_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-4614-4118-2_20","article-title":"Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics","volume":"735","author":"Mehan","year":"2013","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"10.1053\/j.ajkd.2020.03.016_bib36","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/17425255.2018.1511701","article-title":"Biomarkers of drug-induced acute kidney injury: a regulatory perspective","volume":"14","author":"Blank","year":"2018","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.016_bib37","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1681\/ASN.2010080796","article-title":"Biological markers of acute kidney injury","volume":"22","author":"Siew","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.016_bib38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1681\/ASN.2011090907","article-title":"Biomarkers predict progression of acute kidney injury after cardiac surgery","volume":"23","author":"Koyner","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2020.03.016_bib39","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1681\/ASN.2010121302","article-title":"Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery","volume":"22","author":"Parikh","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9466","key":"10.1053\/j.ajkd.2020.03.016_bib40","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery","volume":"365","author":"Mishra","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.016_bib41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ki.2013.333","article-title":"Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery","volume":"85","author":"Arthur","year":"2014","journal-title":"Kidney Int"},{"issue":"20","key":"10.1053\/j.ajkd.2020.03.016_bib42","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1001\/jama.2016.5828","article-title":"Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial","volume":"315","author":"Zarbock","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1053\/j.ajkd.2020.03.016_bib43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/j.ajkd.2003.10.040","article-title":"Urinary interleukin-18 is a marker of human acute tubular necrosis","volume":"43","author":"Parikh","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2020.03.016_bib44","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrneph.2010.128","article-title":"Acute kidney injury: defining prerenal azotemia in clinical practice and research","volume":"6","author":"Parikh","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.016_bib45","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1681\/ASN.2013070742","article-title":"Urinary biomarkers of AKI and mortality 3 years after cardiac surgery","volume":"25","author":"Coca","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2020.03.016_bib46","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1681\/ASN.2014060556","article-title":"Tissue inhibitor metalloproteinase-2 (TIMP-2)IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI","volume":"26","author":"Koyner","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2020.03.016_bib47","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.2215\/CJN.11261210","article-title":"Urinary biomarkers and renal recovery in critically ill patients with renal support","volume":"6","author":"Srisawat","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.016_bib48","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/00365519609088795","article-title":"Renal handling of radiolabelled human cystatin C in the rat","volume":"56","author":"Tenstad","year":"1996","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1053\/j.ajkd.2020.03.016_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1749-8090-9-10","article-title":"Early postoperative serum cystatin C predicts severe acute kidney injury following cardiac surgery: a post-hoc analysis of a randomized controlled trial","volume":"9","author":"Kiessling","year":"2014","journal-title":"J\u00a0Cardiothorac Surg"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2020.03.016_bib51","doi-asserted-by":"crossref","first-page":"41012","DOI":"10.1038\/srep41012","article-title":"Predictive value of serum cystatin C for acute kidney injury in adults: a meta-analysis of prospective cohort trials","volume":"7","author":"Yong","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib52","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2215\/CJN.01300216","article-title":"Biomarkers for the early detection and prognosis of acute kidney injury","volume":"12","author":"Malhotra","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2020.03.016_bib53","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1097\/01.ASN.0000088027.54400.C6","article-title":"Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury","volume":"14","author":"Mishra","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.016_bib54","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1097-2765(02)00708-6","article-title":"The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition","volume":"10","author":"Goetz","year":"2002","journal-title":"Mol Cell"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.016_bib55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1681\/ASN.2006080882","article-title":"Dual action of neutrophil gelatinase-associated lipocalin","volume":"18","author":"Schmidt-Ott","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.016_bib56","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/hep.27447","article-title":"Liver is the major source of elevated serum lipocalin-2 levels after bacterial infection or partial hepatectomy: a critical role for IL-6\/STAT3","volume":"61","author":"Xu","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.016_bib57","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1478-3231.2011.02495.x","article-title":"Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1beta through nuclear factor-kappaB activation","volume":"31","author":"Borkham-Kamphorst","year":"2011","journal-title":"Liver Int"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.016_bib58","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1053\/j.ajkd.2020.03.016_bib59","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00000542-200609000-00011","article-title":"Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery","volume":"105","author":"Wagener","year":"2006","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.016_bib60","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/CCM.0b013e318169245a","article-title":"Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock","volume":"36","author":"Wheeler","year":"2008","journal-title":"Crit Care Med"},{"issue":"6552","key":"10.1053\/j.ajkd.2020.03.016_bib61","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning of a new cytokine that induces IFN-gamma production by T cells","volume":"378","author":"Okamura","year":"1995","journal-title":"Nature"},{"issue":"12","key":"10.1053\/j.ajkd.2020.03.016_bib62","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1681\/ASN.2008020170","article-title":"IL-18 contributes to renal damage after ischemia-reperfusion","volume":"19","author":"Wu","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib63","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1440-1746.2012.07288.x","article-title":"Acute renal failure in cirrhotic patients with severe sepsis: value of urinary interleukin-18","volume":"28","author":"Tsai","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"8","key":"10.1053\/j.ajkd.2020.03.016_bib64","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2215\/CJN.09061209","article-title":"Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes","volume":"5","author":"Siew","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2020.03.016_bib65","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1053\/j.ajkd.2013.05.014","article-title":"Urinary interleukin 18 for detection of acute kidney injury: a meta-analysis","volume":"62","author":"Liu","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2020.03.016_bib66","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.273.7.4135","article-title":"Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury","volume":"273","author":"Ichimura","year":"1998","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib67","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","article-title":"Kidney injury molecule-1 (KIM-1): a novel biomarker for human\u00a0renal proximal tubule injury","volume":"62","author":"Han","year":"2002","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2020.03.016_bib68","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.ki.5002715","article-title":"Urinary biomarkers in the early diagnosis of acute kidney injury","volume":"73","author":"Han","year":"2008","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ajkd.2020.03.016_bib69","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1097\/CCM.0b013e3181eedac0","article-title":"Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury","volume":"38","author":"Doi","year":"2010","journal-title":"Crit Care Med"},{"issue":"11","key":"10.1053\/j.ajkd.2020.03.016_bib70","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1681\/ASN.2007010097","article-title":"Renal L-type fatty acid--binding protein in acute ischemic injury","volume":"18","author":"Yamamoto","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib71","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/cc12503","article-title":"Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury","volume":"17","author":"Kashani","year":"2013","journal-title":"Crit Care"},{"issue":"7","key":"10.1053\/j.ajkd.2020.03.016_bib72","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/1354750X.2019.1652347","article-title":"Urinary cell cycle arrest biomarker [TIMP-2].[IGFBP7] in patients with hepatorenal syndrome","volume":"24","author":"Zhang","year":"2019","journal-title":"Biomarkers"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.016_bib73","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/hep.26556","article-title":"Performance of Chronic Kidney Disease Epidemiology Collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis","volume":"59","author":"Mindikoglu","year":"2014","journal-title":"Hepatology"},{"issue":"48","key":"10.1053\/j.ajkd.2020.03.016_bib74","doi-asserted-by":"crossref","first-page":"9432","DOI":"10.3748\/wjg.v19.i48.9432","article-title":"Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure","volume":"19","author":"Wan","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib75","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.semnephrol.2016.01.008","article-title":"Quantifying glomerular filtration rates in acute kidney injury: a requirement for translational success","volume":"36","author":"Molitoris","year":"2016","journal-title":"Semin Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2020.03.016_bib76","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/apt.12299","article-title":"Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers","volume":"37","author":"Slack","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.016_bib77","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/hep.29290","article-title":"Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis","volume":"66","author":"Markwardt","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.016_bib78","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"Electronic address eee, European Association for the Study of the L. EASL Clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.016_bib79","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatology"},{"issue":"9","key":"10.1053\/j.ajkd.2020.03.016_bib80","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis","volume":"57","author":"Verna","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib81","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.30592","article-title":"Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study","volume":"70","author":"Huelin","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1053\/j.ajkd.2020.03.016_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128145","article-title":"Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis","volume":"10","author":"Ariza","year":"2015","journal-title":"PloS One"},{"key":"10.1053\/j.ajkd.2020.03.016_bib83","doi-asserted-by":"crossref","first-page":"376795","DOI":"10.1155\/2014\/376795","article-title":"Urinary biomarkers of acute kidney injury in patients with liver cirrhosis","volume":"2014","author":"Qasem","year":"2014","journal-title":"ISRN Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.016_bib84","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/nep.13226","article-title":"Biomarkers for acute kidney injury in decompensated cirrhosis: a prospective study","volume":"24","author":"Jaques","year":"2019","journal-title":"Nephrology (Carlton)"},{"key":"10.1053\/j.ajkd.2020.03.016_bib85","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12876-015-0372-5","article-title":"Urine neutrophil gelatinase-associated lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions","volume":"15","author":"Treeprasertsuk","year":"2015","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"10.1053\/j.ajkd.2020.03.016_bib86","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cgh.2016.11.035","article-title":"Urine interleukin 18 and lipocalin 2 are biomarkers of acute tubular necrosis in patients with cirrhosis: a systematic review and meta-analysis","volume":"15","author":"Puthumana","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"10.1053\/j.ajkd.2020.03.016_bib87","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2215\/CJN.09430913","article-title":"Urinary biomarkers and progression of AKI in patients with cirrhosis","volume":"9","author":"Belcher","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2020.03.016_bib88","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.dld.2016.11.001","article-title":"Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis","volume":"49","author":"Yap","year":"2017","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000479074","article-title":"Biomarkers of renal\u00a0injury in cirrhosis: association with acute kidney injury and\u00a0recovery after liver transplantation","volume":"138","author":"Singal","year":"2018","journal-title":"Nephron"},{"issue":"6","key":"10.1053\/j.ajkd.2020.03.016_bib90","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/hep.27346","article-title":"Plasma protein biomarkers enhance the clinical prediction of kidney injury recovery in patients undergoing liver transplantation","volume":"60","author":"Levitsky","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1053\/j.ajkd.2020.03.016_bib91","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/hep.30667","article-title":"External validation of a pretransplant biomarker model (REVERSE) predictive of renal recovery after liver transplantation","volume":"70","author":"Levitsky","year":"2019","journal-title":"Hepatology"},{"issue":"5","key":"10.1053\/j.ajkd.2020.03.016_bib92","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/TP.0000000000002403","article-title":"Changes in simultaneous liver-kidney transplant allocation policy may impact postliver transplant outcomes","volume":"103","author":"Cullaro","year":"2019","journal-title":"Transplantation"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib93","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1038\/s41598-018-26226-6","article-title":"Value of urinary KIM-1 and NGAL combined with serum Cys C for predicting acute kidney injury\u00a0secondary to decompensated cirrhosis","volume":"8","author":"Lei","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib94","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jhep.2014.02.023","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections","volume":"61","author":"Barreto","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib95","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhep.2016.03.002","article-title":"Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver\u00a0failure and prognosis in cirrhosis","volume":"65","author":"Ariza","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1053\/j.ajkd.2020.03.016_bib96","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5604\/01.3001.0012.7907","article-title":"Serum NGAL is superior to cystatin C in predicting the prognosis of acute-on-chronic liver failure","volume":"18","author":"Lu","year":"2018","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1053\/j.ajkd.2020.03.016_bib97","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cgh.2016.09.156","article-title":"Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute-on-chronic liver failure","volume":"15","author":"Huelin","year":"2017","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620306910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638620306910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:28:41Z","timestamp":1759462121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638620306910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":97,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0272638620306910"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.03.016","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Application of Kidney Biomarkers in Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2020.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}